Suscribete

Cancer Research Institute Hosts Fifth Annual Cancer Immunotherapy Month™ in June

30 days of educational and awareness programming and special events for patients, caregivers, and the public about...

Immunotherapy Data from CRI Clinical Accelerator to Be Presented at ASCO Annual Meeting

Data from four CRI-funded early-phase immunotherapy combination trials will be presented at the American Society for Clinical...

CRI Appoints Dr. Aiman Shalabi as Chief Medical Officer to Accelerate Precision Immunotherapy Clinical Collaborations

Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program

BMS, Parker Institute, and CRI Team Up to Advance Immunotherapy Trials

An innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers...

CRI Awards Grant to Develop Powerful Genomic Data Resource

CRI iAtlas to provide immune bioinformatics tool that aims to improve cancer immunotherapy research and drug effectiveness.

CRI Partners with FCF in Rare Liver Cancer Research

The two nonprofits partnered to support four scientists whose research is focused on developing immunotherapies for patients...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.